BR0213734A - Derivados de carboxamida heteroaromático para o tratamento de inflamação - Google Patents
Derivados de carboxamida heteroaromático para o tratamento de inflamaçãoInfo
- Publication number
- BR0213734A BR0213734A BR0213734-8A BR0213734A BR0213734A BR 0213734 A BR0213734 A BR 0213734A BR 0213734 A BR0213734 A BR 0213734A BR 0213734 A BR0213734 A BR 0213734A
- Authority
- BR
- Brazil
- Prior art keywords
- inflammation
- carboxamide derivatives
- treatment
- heteroaromatic carboxamide
- heteroaromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34081601P | 2001-10-30 | 2001-10-30 | |
PCT/US2002/034801 WO2003037886A2 (fr) | 2001-10-30 | 2002-10-30 | Derives de carboxamide heteroaromatique destines au traitement des inflammations |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0213734A true BR0213734A (pt) | 2004-10-19 |
Family
ID=23335051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0213734-8A BR0213734A (pt) | 2001-10-30 | 2002-10-30 | Derivados de carboxamida heteroaromático para o tratamento de inflamação |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1444010A2 (fr) |
JP (1) | JP2005509645A (fr) |
AU (1) | AU2002356871A1 (fr) |
BR (1) | BR0213734A (fr) |
CA (1) | CA2464924A1 (fr) |
MX (1) | MXPA04004064A (fr) |
WO (1) | WO2003037886A2 (fr) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974870B2 (en) | 2002-06-06 | 2005-12-13 | Boehringer Ingelheim Phamaceuticals, Inc. | Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
EA008706B1 (ru) | 2002-06-06 | 2007-06-29 | Бёрингер Ингельхайм Фармасьютиклз, Инк. | АМИДЫ ЗАМЕЩЕННЫХ 3-АМИНОТИЕНО[2,3-b]ПИРИДИН-2-КАРБОНОВЫХ КИСЛОТ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ |
JP2006512313A (ja) | 2002-10-31 | 2006-04-13 | アムジェン インコーポレイテッド | 抗炎症剤 |
US7329764B2 (en) | 2003-07-31 | 2008-02-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substitute benzothiophene compounds |
FR2860792B1 (fr) | 2003-10-10 | 2006-02-24 | Sanofi Synthelabo | Derives de thiophene-2-carboxamide, leur preparation et leur application en therapeutique |
RU2006123704A (ru) * | 2003-12-05 | 2008-01-20 | Берингер Ингельхайм Фармасьютиклз, Инк. (Us) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ АМИДО 3-АМИНОТИЕНО[2, 3-b]ПИРИДИН-2-КАРБОНОВОЙ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ IKK |
GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
AU2005228899A1 (en) * | 2004-03-30 | 2005-10-13 | Novartis Vaccines And Diagnostics, Inc. | Substituted thiophene derivatives as anti-cancer agents |
AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
KR100912998B1 (ko) | 2005-03-29 | 2009-08-20 | 이코스 코포레이션 | Chk1 억제에 유용한 헤테로아릴 우레아 유도체 |
GB0507200D0 (en) * | 2005-04-08 | 2005-05-18 | Smithkline Beecham Corp | Chemical compounds |
US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
CA2613068A1 (fr) | 2005-06-30 | 2007-01-11 | Smithkline Beecham Corporation | Indole carboxamides en tant qu'inhibiteurs d'ikk2 |
WO2007087283A2 (fr) | 2006-01-23 | 2007-08-02 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides utiles en tant qu'inhibiteurs de proteines kinases |
EP2007757B1 (fr) * | 2006-04-13 | 2012-10-03 | Vertex Pharmceuticals Incorporated | Thiophène-carboxamides servant d'inhibiteurs de protéines kinases |
JP5546240B2 (ja) | 2006-04-26 | 2014-07-09 | ジェネンテック, インコーポレイテッド | 医薬化合物 |
US8853244B2 (en) | 2006-05-23 | 2014-10-07 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
US7851495B2 (en) | 2006-05-23 | 2010-12-14 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
US7592353B2 (en) | 2006-06-06 | 2009-09-22 | Boehringer Ingelheim International Gmbh | Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
WO2008020622A1 (fr) * | 2006-08-17 | 2008-02-21 | Kyorin Pharmaceutical Co., Ltd. | NOUVEAU COMPOSÉ DE THIÉNO[2,3-d]PYRIMIDINE |
MY180595A (en) | 2006-12-07 | 2020-12-03 | Genentech Inc | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
EP2207781B1 (fr) | 2007-09-24 | 2012-11-28 | Genentech, Inc. | Composés inhibiteurs de la pi3k à base de thiazolopyrimidine et les procédés pour l'utilisation |
PE20131210A1 (es) | 2007-12-19 | 2013-10-31 | Genentech Inc | Derivados de 5-anilinoimidazopiridina como inhibidores de mek |
WO2009082687A1 (fr) | 2007-12-21 | 2009-07-02 | Genentech, Inc. | Azaindolizines et procédés d'utilisation |
RU2545080C2 (ru) | 2009-02-05 | 2015-03-27 | Иммьюноджен, Инк. | Новые производные бензодиазепина |
JP2012520257A (ja) | 2009-03-10 | 2012-09-06 | グラクソ グループ リミテッド | Ikk2阻害剤としてのインドール誘導体 |
WO2010105008A2 (fr) | 2009-03-12 | 2010-09-16 | Genentech, Inc. | Combinaisons de composés inhibiteurs de phosphoinositide 3-kinase et d'agents chimiothérapeutiques pour le traitement de tumeurs malignes hématopoïétiques |
BRPI1013328A2 (pt) * | 2009-04-16 | 2016-03-29 | Telik Inc | 4-amino-benzoil-2-(fenilamino) tiofeno-3-carbonitrilas substituídas e 4-a-mino-5benzoil-2-(fenilamino) tiofeno-3-carboxamidas substituídas como inibidores da polimerização de tubulina |
JP5546636B2 (ja) | 2009-09-28 | 2014-07-09 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | ベンゾキセピンpi3k阻害剤化合物及び使用方法 |
WO2011049625A1 (fr) | 2009-10-20 | 2011-04-28 | Mansour Samadpour | Procédé de criblage d'aflatoxine dans des produits |
CA3022722A1 (fr) | 2009-11-05 | 2011-05-12 | Rhizen Pharmaceuticals S.A. | Modulateurs de proteine kinase pi3k |
CN105001334A (zh) | 2010-02-10 | 2015-10-28 | 伊缪诺金公司 | Cd20抗体及其用途 |
PL2675479T3 (pl) | 2011-02-15 | 2016-09-30 | Cytotoksyczne pochodne benzodiazepiny | |
EA024842B9 (ru) | 2011-05-04 | 2017-08-31 | Ризен Фармасьютикалз Са | Соединения в качестве модуляторов протеинкиназы pi3k |
NZ702244A (en) | 2012-06-08 | 2017-06-30 | Hoffmann La Roche | Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer |
DK3260455T3 (da) | 2012-07-04 | 2019-06-11 | Rhizen Pharmaceuticals S A | Selektive pi3k delta-hæmmere |
EP2887965A1 (fr) | 2012-08-22 | 2015-07-01 | ImmunoGen, Inc. | Dérivés de benzodiazépine cytotoxique |
WO2014134483A2 (fr) | 2013-02-28 | 2014-09-04 | Immunogen, Inc. | Conjugués comprenant des agents de liaison cellulaire (cba) et des agents cytotoxiques |
EP2961435B1 (fr) | 2013-02-28 | 2019-05-01 | ImmunoGen, Inc. | Conjugués comprenant des agents de liaison cellulaire (cba) et des agents cytotoxiques |
WO2014194030A2 (fr) | 2013-05-31 | 2014-12-04 | Immunogen, Inc. | Conjugués comprenant des agents de liaison cellulaire et des agents cytotoxiques |
AR104068A1 (es) | 2015-03-26 | 2017-06-21 | Hoffmann La Roche | Combinaciones de un compuesto inhibidor de fosfoinosítido 3-cinasa y un compuesto inhibidor de cdk4/6 para el tratamiento del cáncer |
EP3507305A1 (fr) | 2016-09-02 | 2019-07-10 | Dana-Farber Cancer Institute, Inc. | Composition et méthodes de traitement des déreglements des lymphocytes b |
US11000491B2 (en) | 2017-05-05 | 2021-05-11 | Hepanova, Inc. | Amino-aryl-benzamide compounds and methods of use thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1360982A (en) * | 1970-08-27 | 1974-07-24 | Beecham Group Ltd | Derivatives of 1-phenyl-5-aminoimidazole and compositions thereof |
US3864359A (en) * | 1972-05-01 | 1975-02-04 | American Cyanamid Co | 5-amino-3-ethyl-1-phenyl-4-pyrazolecarboxamides and method of preparation thereof |
US4264495A (en) * | 1972-05-15 | 1981-04-28 | Eastman Kodak Company | 2-Thienyl azo dyestuff compounds |
GB1468012A (en) * | 1973-08-09 | 1977-03-23 | Beecham Group Ltd | 2-amino-3-carboxy-thiophene derivatives |
DD236530A1 (de) * | 1985-04-26 | 1986-06-11 | Univ Halle Wittenberg | Verfahren zur herstellung von 2-cyano-2-(4h-4-oxo-1,2,dihydro-thieno 2,3-d 1,3 thiazin-2-yliden)-essigsaeureestern |
DD263055A1 (de) * | 1987-07-28 | 1988-12-21 | Univ Dresden Tech | Verfahren zur herstellung substituierter 3-amino-5-phenyl-thiophene |
DE3914430A1 (de) * | 1988-05-05 | 1989-11-16 | Ciba Geigy Ag | Azofarbstoffe, verfahren zu deren herstellung und deren verwendung |
DE4019168A1 (de) * | 1989-06-19 | 1990-12-20 | Ciba Geigy Ag | Azofarbstoffe, deren herstellung und verwendung |
GB0003154D0 (en) * | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
JP2002105081A (ja) * | 2000-07-28 | 2002-04-10 | Nikken Chem Co Ltd | 新規チオフェンニ環化合物 |
EP1324759A4 (fr) * | 2000-10-12 | 2004-05-12 | Smithkline Beecham Corp | Inhibiteurs du nf-g(k)b |
SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
WO2003028731A1 (fr) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Inhibiteurs de kinase chk1 |
-
2002
- 2002-10-30 WO PCT/US2002/034801 patent/WO2003037886A2/fr not_active Application Discontinuation
- 2002-10-30 CA CA002464924A patent/CA2464924A1/fr not_active Abandoned
- 2002-10-30 EP EP02802495A patent/EP1444010A2/fr not_active Withdrawn
- 2002-10-30 JP JP2003540167A patent/JP2005509645A/ja not_active Withdrawn
- 2002-10-30 MX MXPA04004064A patent/MXPA04004064A/es unknown
- 2002-10-30 AU AU2002356871A patent/AU2002356871A1/en not_active Abandoned
- 2002-10-30 BR BR0213734-8A patent/BR0213734A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2003037886A2 (fr) | 2003-05-08 |
AU2002356871A1 (en) | 2003-05-12 |
WO2003037886A3 (fr) | 2003-12-24 |
JP2005509645A (ja) | 2005-04-14 |
EP1444010A2 (fr) | 2004-08-11 |
CA2464924A1 (fr) | 2003-05-08 |
MXPA04004064A (es) | 2004-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0213734A (pt) | Derivados de carboxamida heteroaromático para o tratamento de inflamação | |
BR0212617A (pt) | Compostos de pirazolila substituìdo para o tratamento de inflamação | |
BR0212613A (pt) | Compostos de indazol substituìdos para o tratamento de inflamação | |
BR0212611A (pt) | Compostos de pirazolila substituìdos para o tratamento da inflamação | |
BR0212661A (pt) | Compostos de pirazolil benzenossulfamida substituìdos para o tratamento de inflamação | |
NL300933I2 (nl) | Letermovir | |
DOP2002000429A (es) | Imidazotriazinas | |
BR0307796A (pt) | Derivados tricìclicos de pirazol para o tratamento de inflamação | |
NO20034056D0 (no) | Proliferative sykdommer | |
WO2004041203A3 (fr) | Promedicaments de gemcitabine, leurs compositions pharmaceutiques et leurs utilisations | |
ATE408601T1 (de) | Fredericamycin-derivate | |
DE60231439D1 (de) | Mitotische kinesinhemmer | |
DE60234278D1 (de) | Mitotische kinesin-hemmer | |
UY26130A1 (es) | Compuestos para tratar la obesidad | |
PA8571001A1 (es) | 2-(2,6-diclorofenil)-diarilimidazoles | |
EE200300559A (et) | Osteopontiini kasutamine neuroloogiliste haigusteraviks ja/või vältimiseks | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
NO20055307D0 (no) | Substituerte isokromanforbindelser for behandling av metabolske forstyrrelser, kreft og andre sykdommer | |
EP1251126A3 (fr) | Derives de benzenesulfonyle a substitution fluor pour le traitment d'inflammation | |
BR0117009A (pt) | Composiçoes para utilização no tratamento de distúrbios associados a ige | |
PA8529701A1 (es) | Compuestos retinoides | |
NO20033803D0 (no) | Karbamat for behandling av bevegelseslidelser | |
BRPI0411864A (pt) | combinação de inibidores de src quinase e agentes quimioterápicos para o tratamento de doenças proliferativas | |
BRPI0411176A (pt) | combinação farmacêutica consistindo de modafinil e outra droga | |
DE60233350D1 (de) | IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 5O, 6O E 7O ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2034 DE 29/12/2009. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: C07D 333/38 (2006.01), A61P 29/00 (2006.01), C07D |